Connection
David Camidge to Karyopherins
This is a "connection" page, showing publications David Camidge has written about Karyopherins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.237 |
|
|
|
-
von Itzstein MS, Burns TF, Dowell JE, Horn L, Camidge DR, York SJ, Eaton KD, Kyle K, Fattah F, Liu J, Mu-Mosley H, Gupta A, Nadeem U, Gao A, Zhang S, Gerber DE. Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer. Clin Cancer Res. 2025 Feb 17; 31(4):639-648.
Score: 0.237